FDA NDC Directory · JSON-LD · Markdown

Ondansetron

NDC 43063-273 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerPD-Rx Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA078152
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (8 mg/1)
Marketing started20070627
Package count1

External sources

Source: openFDA. Public-domain (CC0).